You are here

  • Home
  • Archive
  • Volume 76, Issue 9
  • Correction: Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study

Article metrics

Article menu

Download PDFPDF

Miscellaneous
Correction: Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study

 

Online download statistics by month:

Online download statistics by month: August 2017 to April 2025

AbstractFullPdf
Aug 2017362368110
Sep 201711311464
Oct 2017838421
Nov 2017363716
Dec 2017373810
Jan 201838389
Feb 2018424010
Mar 201831319
Apr 201826273
May 2018525317
Jun 201824244
Jul 2018343413
Aug 201825259
Sep 201822227
Oct 201820207
Nov 201818183
Dec 201822229
Jan 201912111
Feb 201911111
Mar 201919187
Apr 201914126
May 201913126
Jun 201914147
Jul 201917177
Aug 2019774
Sep 201918177
Oct 201914147
Nov 2019191711
Dec 2019111010
Jan 202011117
Feb 202010103
Mar 202018177
Apr 2020161611
May 202013125
Jun 2020121210
Jul 2020993
Aug 2020996
Sep 202030303
Oct 202019187
Nov 202020174
Dec 202011114
Jan 202119196
Feb 2021884
Mar 2021181810
Apr 2021551
May 2021885
Jun 2021232312
Jul 2021111111
Aug 2021888
Sep 202110107
Oct 20219719
Nov 2021111114
Dec 202110101
Jan 202213136
Feb 2022995
Mar 202216174
Apr 2022171910
May 2022313216
Jun 202226266
Jul 202216153
Aug 202232335
Sep 2022212015
Oct 202223227
Nov 202215151
Dec 2022883
Jan 202326269
Feb 202334336
Mar 202335355
Apr 202315156
May 202313129
Jun 2023771
Jul 2023336
Aug 2023777
Sep 202315157
Oct 2023771
Nov 202315132
Dec 202311113
Jan 2024883
Feb 202416165
Mar 2024886
Apr 20241094
May 202412122
Jun 2024775
Jul 202411102
Aug 2024663
Sep 202411115
Oct 202421174
Nov 202428265
Dec 202411100
Jan 202512104
Feb 2025550
Mar 2025440
Apr 2025446
Total20612041760